COMMUNIQUÉS West-GlobeNewswire

-
Autonomix Medical, Inc. (NASDAQ: AMIX) Participates in Virtual Investor “What This Means” Segment Highlighting Key Learnings from First-In-Human Trial and Extension into Visceral Cancer Pain
01/05/2025 -
Celebrity Trainer Pieter Vodden Partners with Campio to Promote Daily Joint Support for Active Lifestyles
01/05/2025 -
Lexeo Therapeutics to Present New CMC Data at the 28th American Society of Gene & Cell Therapy (ASGCT) Annual Meeting
01/05/2025 -
SRx Health Solutions to Consider Allocating Up to 10% of Future Cash Flows and Cash Reserves to Bitcoin, Solana and Gold
01/05/2025 -
Intuitive Announces FDA Clearance of da Vinci Single Port for Transanal Local Excision/Resection
01/05/2025 -
Senti Bio Releases Virtual Investor “What This Means” Segment
01/05/2025 -
Lyell Immunopharma Announces Oral Presentation of New Clinical Data from the Phase 1/2 Trial of LYL314 for the Treatment of Large B-cell Lymphoma at the International Conference on Malignant Lymphoma (ICML) 2025
01/05/2025 -
HeartSciences Announces Launch of MyoVista Insights™ Platform and Related Early Adopter Program
01/05/2025 -
Precision Neuroscience Adds Med-Tech Veterans To Accelerate Commercialization
01/05/2025 -
Eleos Advances Comprehensive Behavioral Health Product Capabilities
01/05/2025 -
Resmed Acquires VirtuOx
01/05/2025 -
Dupixent® (dupilumab) Data Presented at ATS Reinforce Impact of Targeting Key Type 2 Inflammation Drivers to Improve Outcomes for Chronic Respiratory Diseases
01/05/2025 -
Promex Industries Expands Best-in-Class Capabilities, Installing Laser Depaneling and Advanced SPI Systems on Manufacturing Line
01/05/2025 -
BioCardia Announces First Patient in Phase 3 Randomized Controlled Double-Blind CardiAMP HF II Clinical Trial of the Company’s Lead Cell Therapy for Treatment of Heart Failure
01/05/2025 -
SPR Expands Access to the SPRINT® PNS System for Veterans with New Distribution Agreement with Veteran’s Health Medical Supply
01/05/2025 -
RoomSync Partners with Counslr to Launch the Fall Pass to Improve Community Well-being and Increase Revenue
01/05/2025 -
Akari Therapeutics Appoints Mark F. Kubik as Head of Business Development - Oncology
01/05/2025 -
Veru to Report Fiscal 2025 Second Quarter Financial Results on May 8
01/05/2025 -
Wave Life Sciences First Quarter 2025 Financial Results Scheduled for May 8, 2025
01/05/2025
Pages